Intravenous Infusions Plc announced audited earnings results for the year ended December 31, 2017. For the year, the company’s revenue was GHS 16,371,794 compared to GHS 10,596,009 a year ago. PBDIT was GHS 4,648,771 compared to GHS 1,972,685 a year ago. PBIT was GHS 4,161,419 compared to GHS 1,684,448 a year ago. Profit before tax was GHS 3,251,228 compared to GHS 1,168,652 a year ago. Profit after tax was GHS 2,730,682 compared to GHS 669,945 a year ago. Basic and diluted EPS was GHS 0.01205 compared to GHS 0.00296 a year ago. Net cash used in operating activities was GHS 637,701 compared to GHS 4,299,593 a year ago. Cash paid for property, plant and equipment was GHS 1,242,467 compared to GHS 803,769 a year ago.